-
1دورية أكاديمية
المؤلفون: Bal T., Önlen Y., Çabalak M., Öztoprak N.Ç., Sarı N.D., Kurtaran B., Şenateş E.
مصطلحات موضوعية: chronic hepatitis C, Age, direct-acting antiviral agents, elderly, Turkey, antivirus agent, dasabuvir plus ombitasvir plus paritaprevir plus ritonavir, ledipasvir plus sofosbuvir, ribavirin, sofosbuvir, adult, aged, anemia, angioneurotic edema, Article, bleeding, cohort analysis, constipation, decompensated liver cirrhosis, demography, drug efficacy, drug safety, drug withdrawal, dyspnea, fatigue, female, groups by age, headache, Hepatitis C virus genotype 1, human
العلاقة: Turkish Journal of Gastroenterology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11454/80027Test; https://doi.org/10.5152/tjg.2022.21271Test; 33; 10; 862; 873
-
2دورية أكاديمية
المؤلفون: Önlen Y., Bal T., Çabalak M., Öztoprak N.Ç., Sarı N.D., Kurtaran B., Şenateş E.
مصطلحات موضوعية: Age, chronic hepatitis C, direct-acting antiviral agents, elderly, Turkey, antivirus agent, dasabuvir plus ombitasvir plus paritaprevir plus ritonavir, ledipasvir plus sofosbuvir, ribavirin, sofosbuvir, adult, aged, anemia, angioneurotic edema, Article, bleeding, cohort analysis, constipation, decompensated liver cirrhosis, demography, drug efficacy, drug safety, drug withdrawal, dyspnea, fatigue, female, groups by age, headache, Hepatitis C virus genotype 1, human
العلاقة: Turkish Journal of Gastroenterology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.5152/tjg.2022.21271Test; https://hdl.handle.net/11454/80027Test; 33; 10; 862; 873; 2-s2.0-85139571415
-
3دورية أكاديمية
المؤلفون: Amele, S, Peters, L, Rodger, A, Lundgren, J, Rockstroh, J, Matulionyte, R, Leen, C, Jablonowska, E, Ostergaard, L, Bhagani, S, Sarcletti, M, Clarke, A, Falconer, K, Wandeler, G, Domingo, P, Maltez, F, Zaccarelli, M, Chkhartisvili, N, Szlavik, J, Stephan, C, Fonquernie, L, Aho, I, Mocroft, A, Group, ES
المساهمون: HUS Internal Medicine and Rehabilitation, Clinicum
مصطلحات موضوعية: HIV, HCV coinfection, DAA treatment, DAA safety, SVR, Europe, HUMAN-IMMUNODEFICIENCY-VIRUS, DACLATASVIR PLUS SOFOSBUVIR, HCV, EFFICACY, LEDIPASVIR, INFECTION, MORTALITY, REGIMENS, 3121 General medicine, internal medicine and other clinical medicine
وصف الملف: application/pdf
العلاقة: Amele , S , Peters , L , Rodger , A , Lundgren , J , Rockstroh , J , Matulionyte , R , Leen , C , Jablonowska , E , Ostergaard , L , Bhagani , S , Sarcletti , M , Clarke , A , Falconer , K , Wandeler , G , Domingo , P , Maltez , F , Zaccarelli , M , Chkhartisvili , N , Szlavik , J , Stephan , C , Fonquernie , L , Aho , I , Mocroft , A & Group , ES 2021 , ' Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study ' , Journal of acquired immune deficiency syndromes , vol. 86 , no. 2 , pp. 248-257 . https://doi.org/10.1097/QAI.0000000000002541Test; RIS: urn:A472A1FF46B8DBD2F132F90B99CB294C; http://hdl.handle.net/10138/335642Test; ab87ef2b-9383-4d1b-bdb2-143209870c57; 000658815500020
-
4دورية أكاديمية
المؤلفون: Varón A., Santos L., Tapias M., Cáez C., Marín J.I., Santos Ó., Garzón M., Beltrán Ó., Gómez-Aldana A., Yepes I.J., Rondón M., Rosselli D.
المصدر: instname:Universidad del Rosario
مصطلحات موضوعية: Alanine aminotransferase, Antivirus agent, Aspartate aminotransferase, Asunaprevir, Biological marker, Daclatasvir, Daclatasvir plus ribavirin, Daclatasvir plus simeprevir, Dasabuvir, Ledipasvir, Ledipasvir plus ribavirin, Ledipasvir plus sofosbuvir, Ombitasvir, Paritaprevir, Paritaprevir plus ribavirin, Ribavirin, Ribavirin plus sofosbuvir, Ritonavir, Simeprevir, Sofosbuvir, Unclassified drug, Virus rna, Adult, Aged, Alanine aminotransferase blood level, Anemia, Anxiety disorder, Article, Aspartate aminotransferase blood level, Asthenia
وصف الملف: application/pdf
-
5دورية أكاديمية
المؤلفون: Patel, S.V., Jayaweera, D.T., Althoff, K.N., Eron, J.J., Radtchenko, J., Mills, A., Moyle, G., Santiago, S., Sax, P.E., Gillman, J., Mounzer, K., Elion, R.A., Huhn, G.D.
المصدر: PLoS ONE, 15(2)
مصطلحات موضوعية: ledipasvir plus sofosbuvir, elbasvir plus grazoprevir, alanine aminotransferase, aspartate aminotransferase, sofosbuvir, ribavirin, sofosbuvir plus velpatasvir, daclatasvir, peginterferon, dasabuvir plus ombitasvir plus paritaprevir plus ritonavir, simeprevir
العلاقة: https://doi.org/10.17615/5qhn-ad14Test; https://cdr.lib.unc.edu/downloads/6682x9962?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/6682x9962Test
الإتاحة: https://doi.org/10.17615/5qhn-ad14Test
https://cdr.lib.unc.edu/downloads/6682x9962?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/6682x9962Test -
6دورية أكاديمية
المؤلفون: Bielen, Rob, Koc, Özgür M, Busschots, Dana, Robaeys, Geert, Aertgeerts, Bert, Vaes, Bert, Mamouris, Pavlos, Mathei, Catharina, Goderis, Geert, Nevens, Frederik
المصدر: Bielen , R , Koc , Ö M , Busschots , D , Robaeys , G , Aertgeerts , B , Vaes , B , Mamouris , P , Mathei , C , Goderis , G & Nevens , F 2019 , ' Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium : a registry-based study ' , BMJ Open , vol. 9 , no. 5 , 026464 , pp. 1-9 . https://doi.org/10.1136/bmjopen-2018-026464Test
مصطلحات موضوعية: VIRUS GENOTYPE 1, PRIMARY-CARE, PLUS SOFOSBUVIR, CHRONIC HCV, PREVALENCE, INFECTION, RIBAVIRIN, EPIDEMIOLOGY
الإتاحة: https://doi.org/10.1136/bmjopen-2018-026464Test
https://cris.maastrichtuniversity.nl/en/publications/68114810-1c74-420e-be03-21bddafbba81Test -
7دورية أكاديمية
المؤلفون: Calvaruso, Vincenza, Mazzarelli, Chiara, Milazzo, Laura, Badia, Lorenzo, Pasulo, Luisa, Guaraldi, Giovanni, Lionetti, Raffaella, Villa, Erica, Borghi, Vanni, Carrai, Paola, Alberti, Alfredo, Biolato, Marco, Piai, Guido, Persico, Marcello, Santantonio, Teresa, Felder, Martina, Angelico, Mario, Montalbano, Marzia, Mancusi, Rossella Letizia, Grieco, Antonio, Angeli, Elena, D'Offizi, Gianpiero, Fagiuoli, Stefano, Belli, Luca, Verucchi, Gabriella, Puoti, Massimo, Craxì, Antonio
المساهمون: Calvaruso, Vincenza, Mazzarelli, Chiara, Milazzo, Laura, Badia, Lorenzo, Pasulo, Luisa, Guaraldi, Giovanni, Lionetti, Raffaella, Villa, Erica, Borghi, Vanni, Carrai, Paola, Alberti, Alfredo, Biolato, Marco, Piai, Guido, Persico, Marcello, Santantonio, Teresa, Felder, Martina, Angelico, Mario, Montalbano, Marzia, Mancusi, Rossella Letizia, Grieco, Antonio, Angeli, Elena, D'Offizi, Gianpiero, Fagiuoli, Stefano, Belli, Luca, Verucchi, Gabriella, Puoti, Massimo, Craxì, Antonio
مصطلحات موضوعية: SUSTAINED VIROLOGICAL RESPONSE, ADVANCED LIVER-DISEASE, CHRONIC HEPATITIS-C, VIRUS GENOTYPE 3, PLUS SOFOSBUVIR, INFECTION, RIBAVIRIN, EFFICACY, SAFETY
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30679515; info:eu-repo/semantics/altIdentifier/wos/WOS:000456554600024; volume:9; issue:1; firstpage:585; lastpage:592; numberofpages:8; journal:SCIENTIFIC REPORTS; http://hdl.handle.net/11585/670085Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85060550956; https://www.nature.com/articles/s41598-018-36734-0#Ack1Test
الإتاحة: https://doi.org/10.1038/s41598-018-36734-0Test
http://hdl.handle.net/11585/670085Test
https://www.nature.com/articles/s41598-018-36734-0#Ack1Test -
8دورية أكاديمية
المؤلفون: van der Ree, Meike H., Stelma, Femke, Willemse, Sophie B., Brown, Anthony, Swadling, Leo, van der Valk, Marc, Sinnige, Marjan J., van Nuenen, Ad C., de Vree, J. Marleen L., Klenerman, Paul, Barnes, Eleanor, Kootstra, Neeltje A., Reesink, Hendrik W.
المصدر: van der Ree , M H , Stelma , F , Willemse , S B , Brown , A , Swadling , L , van der Valk , M , Sinnige , M J , van Nuenen , A C , de Vree , J M L , Klenerman , P , Barnes , E , Kootstra , N A & Reesink , H W 2017 , ' Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing ' , Antiviral Research , vol. 146 , pp. 139-145 . https://doi.org/10.1016/j.antiviral.2017.08.016Test
مصطلحات موضوعية: Chronic hepatitis C, DAA treatment, Immune response, miRNA-122, HUMAN HEPATOCELLULAR-CARCINOMA, DACLATASVIR PLUS SOFOSBUVIR, DIRECT-ACTING ANTIVIRALS, INTERFERON-FREE THERAPY, ADVANCED LIVER-DISEASE, VIRUS GENOTYPE 3, T-CELLS, NATURAL-KILLER, PHASE-III, CYCLIN G1
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1016/j.antiviral.2017.08.016Test
https://hdl.handle.net/11370/aa8b9e9c-4bd1-4c1e-80ec-278cc194fd21Test
https://research.rug.nl/en/publications/aa8b9e9c-4bd1-4c1e-80ec-278cc194fd21Test
https://pure.rug.nl/ws/files/50617822/1_s2.0_S016635421730390X_main.pdfTest -
9دورية أكاديمية
المؤلفون: van der Ree, MH, Stelma, F, Willemse, SB, Brown, A, Swadling, L, van der Valk, M, Sinnige, MJ, van Nuenen, AC, de Vree, JML, Klenerman, P, Barnes, E, Kootstra, NA, Reesink, HW
المصدر: Antiviral Research , 146 pp. 139-145. (2017)
مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Pharmacology & Pharmacy, Virology, Chronic hepatitis C, DAA treatment, Immune response, miRNA-122, HUMAN HEPATOCELLULAR-CARCINOMA, DACLATASVIR PLUS SOFOSBUVIR, DIRECT-ACTING ANTIVIRALS, INTERFERON-FREE THERAPY, ADVANCED LIVER-DISEASE, VIRUS GENOTYPE 3, T-CELLS, NATURAL-KILLER, PHASE-III, CYCLIN G1
وصف الملف: text
العلاقة: https://discovery.ucl.ac.uk/id/eprint/10112380/1/1-s2.0-S016635421730390X-main.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10112380Test/
-
10
المؤلفون: Hızel, Kenan, Türker, Kamuran, Tosun, Selma, Önlen, Yusuf, Bal, Tayibe, Çabalak, Mehmet, Çuvalcı Öztoprak, Nefise, Sarı, Nagehan Didem, Kurtaran, Behice, Şenateş, Ebubekir, Gündüz, Alper, Zerdali, Esra, Karsen, Hasan, Batırel, Ayşe, Karaali, Rıdvan, Güner, Rahmet, Yamazhan, Tansu, Erben, Nurettin, İnce, Nevin, Köksal, İftihar, Sarıgül Yıldırım, Figen, Yörük, Gülşen, Kömür, Süheyla, Kaya, Sibel, Esen, Şaban, Günal, Özgür, Esen Yıldız, İlknur, İnan, Dilara, Barut, Şener, Namıduru, Mustafa, Köse, ŞÜKRAN, Tabak, Fehmi, Sırmatel, Fatma, Kumbasar Karaosmanoğlu, Hayat, Karabay, Oğuz, Sünnetçioğlu, Mahmut, Çelebi, Güven, Akbulut, Ayhan, Gül, Hanefi Cem, User, Ülkü, Can, Güray, Akıncı, Esragül, Duygu, Fazilet, Baykam, Nurcan, Şener, Alper
المساهمون: RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Yıldız, İlknur Esen
مصطلحات موضوعية: antivirus agent, Male, demography, drug safety, Turkey, Sustained Virologic Response, insomnia, groups by age, Hepacivirus, Turkey (republic), angioneurotic edema, urticaria, Elderly, middle aged, genetics, psychosis, Prospective Studies, adult, clinical trial, cohort analysis, nausea, anemia, medical history, Hepatitis C virus genotype 1, aged, female, Treatment Outcome, drug withdrawal, young adult, Drug Therapy, Combination, headache, prospective study, combination drug therapy, liver cell carcinoma, direct-acting antiviral agents, hyperbilirubinemia, ribavirin, liver cirrhosis, sex difference, elderly, sofosbuvir, Antiviral Agents, Article, Age, turkey (bird), chronic hepatitis C, Humans, human, nonhuman, ledipasvir plus sofosbuvir, constipation, dyspnea, pruritus, Hepatitis C, Chronic, bleeding, major clinical study, drug efficacy, dasabuvir plus ombitasvir plus paritaprevir plus ritonavir, multicenter study, Direct-acting antiviral agents, fatigue, observational study, Chronic Hepatitis C, population research, decompensated liver cirrhosis
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8532322340ef51fc04642059311e0d31Test
https://hdl.handle.net/11454/80027Test